Evidence map›Paper›PMID 31934306›Full record

ArticleAmerican journal of translational research2019

Human gingiva tissue-derived MSC ameliorates immune-mediated bone marrow failure of aplastic anemia

Jianzhi Zhao, Jingrong Chen, Feng Huang, Julie Wang, Wenru Su, Jianyao Zhou, Quanyin Qi, Fenglin Cao, Baoqing Sun, Zhongmin Liu and 2 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Jianzhi ZhaoDivision of Hematology, Shaoxing Central Hospital Shaoxing, China.
Jingrong ChenDepartment of Clinical Immunology in Third Affiliated Hospital of The Sun Yat-sen University Guangzhou, China.
Feng HuangDepartment of Clinical Immunology in Third Affiliated Hospital of The Sun Yat-sen University Guangzhou, China.
Julie WangDivision of Rheumatology and Immunology, Department of Internal Medicine at The Ohio State University College of Medicine Columbus, OH, USA.
Wenru SuDepartment of Clinical Immunology in Third Affiliated Hospital of The Sun Yat-sen University Guangzhou, China.
Jianyao ZhouDivision of Hematology, Shaoxing Central Hospital Shaoxing, China.
Quanyin QiState Key Lab at Guiling Medical College Guiling, China.
Fenglin CaoDepartment of Internal Medicine in The First Affiliated Hospital at The Harbin Medical University Harbin, China.
Baoqing SunDepartment of Allergy and Clinical Immunology, The First Affiliated Hospital at The Guangzhou Medical University Guangzhou, China.
Zhongmin LiuCenter of Stem Cell, Shanghai East Hospital at The Tongji University Shanghai, China.
Joseph A BellantiDepartment of Pediatrics and Microbiology-Immunology, Georgetown University Medical Center Washington, DC, USA.
Songguo ZhengDivision of Rheumatology and Immunology, Department of Internal Medicine at The Ohio State University College of Medicine Columbus, OH, USA.
Sun Yat-sen University · CNXian Central Hospital · CNAffiliated Hospital of Guilin Medical College · CNColumbus State Community College · USFirst Affiliated Hospital of Guangzhou Medical University · CNGeorgetown University · USHarbin Medical University · CNShanghai East Hospital · CNThe Ohio State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence has revealed that human gingiva-derived mesenchymal stem cells (GMSCs) are emerging as a new line of mesenchymal stem cells and may have the potential to control or even treat autoimmune diseases through maintaining the balance between Th and Treg cells. Given that GMSCs have a robust immune regulatory function and regenerative ability, we investigated the effect of GMSCs on preventing T cell-mediated bone marrow failure (BMF) in a mouse model. We observed that GMSCs markedly improved mice survival and attenuated histological bone marrow (BM) damage. Moreover, we found GMSCs significantly reduced cell infiltration of CD8+ cells, Th1 and Th17 cells, whereas increased CD4+Foxp3+ regulatory T cells (Tregs) differentiation in lymph nodes. GMSCs also suppressed the levels of TNF-α, IFN-γ, IL-17A and IL-6, but IL-10 was increased in serum. The live

Indexed as

bone marrow failureGMSCTh1Th17Treg

Identifiers

PMID31934306
PMCPMC6943455
OpenAlexW3003477963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.